News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
362,468 Results
Type
Article (10713)
Company Profile (21)
Press Release (351732)
Multimedia
Podcasts (14)
Webinars (3)
Section
Business (98191)
Career Advice (417)
Deals (20806)
Drug Delivery (39)
Drug Development (46096)
Employer Resources (31)
FDA (9270)
Job Trends (9436)
News (177777)
Policy (18652)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
Academia (1701)
Accelerated approval (21)
Adcomms (13)
Allergies (94)
Alliances (24111)
ALS (115)
Alzheimer's disease (1092)
Antibody-drug conjugate (ADC) (200)
Approvals (9584)
Artificial intelligence (318)
Autoimmune disease (106)
Automation (23)
Bankruptcy (180)
Best Places to Work (8961)
BIOSECURE Act (4)
Biosimilars (99)
Biotechnology (21)
Bladder cancer (120)
Brain cancer (45)
Breast cancer (403)
Cancer (3441)
Cardiovascular disease (248)
Career advice (365)
Career pathing (6)
CAR-T (226)
CDC (15)
Celiac Disease (1)
Cell therapy (518)
Cervical cancer (33)
Clinical research (40916)
Collaboration (1087)
Compensation (290)
Complete response letters (31)
COVID-19 (1384)
CRISPR (57)
C-suite (485)
Cystic fibrosis (85)
Data (4716)
Denatured (4)
Depression (81)
Diabetes (312)
Diagnostics (4379)
Digital health (32)
Diversity (4)
Diversity, equity & inclusion (12)
Drug discovery (149)
Drug pricing (71)
Drug shortages (21)
Duchenne muscular dystrophy (139)
Earnings (44096)
Editorial (21)
Employer branding (1)
Employer resources (27)
Events (55897)
Executive appointments (570)
FDA (11728)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (7)
Frontotemporal dementia (17)
Funding (930)
Gene editing (122)
Generative AI (24)
Gene therapy (358)
GLP-1 (424)
Government (2635)
Grass and pollen (2)
Guidances (322)
Healthcare (14340)
HIV (35)
Huntington's disease (24)
IgA nephropathy (69)
Immunology and inflammation (120)
Immuno-oncology (37)
Indications (84)
Infectious disease (1549)
Inflammatory bowel disease (123)
Inflation Reduction Act (8)
Influenza (84)
Intellectual property (185)
Interviews (68)
IPO (11165)
IRA (23)
Job creations (805)
Job search strategy (297)
JPM (15)
Kidney cancer (13)
Labor market (21)
Layoffs (92)
Leadership (9)
Legal (3949)
Liver cancer (65)
Longevity (6)
Lung cancer (455)
Lymphoma (285)
Machine learning (25)
Management (11)
Manufacturing (472)
MASH (115)
Medical device (9271)
Medtech (9304)
Mergers & acquisitions (10505)
Metabolic disorders (726)
Multiple sclerosis (102)
NASH (10)
Neurodegenerative disease (183)
Neuropsychiatric disorders (49)
Neuroscience (1879)
NextGen: Class of 2026 (4957)
Non-profit (3960)
Obesity (287)
Opinion (126)
Ovarian cancer (129)
Pain (140)
Pancreatic cancer (172)
Parkinson's disease (183)
Partnered (11)
Patents (369)
Patient recruitment (356)
Peanut (32)
People (28439)
Pharmaceutical (9)
Pharmacy benefit managers (15)
Phase 1 (13146)
Phase 2 (18176)
Phase 3 (13378)
Pipeline (3922)
Policy (93)
Postmarket research (1040)
Preclinical (4924)
Press Release (58)
Prostate cancer (147)
Psychedelics (22)
Radiopharmaceuticals (194)
Rare diseases (514)
Real estate (2302)
Recruiting (10)
Regulatory (15029)
Reports (20)
Research institute (1475)
Resumes & cover letters (64)
Rett syndrome (22)
RNA editing (6)
RSV (43)
Schizophrenia (100)
Series A (159)
Series B (118)
Service/supplier (2)
Sickle cell disease (62)
Special edition (23)
Spinal muscular atrophy (75)
Sponsored (19)
Startups (1281)
State (1)
Stomach cancer (9)
Supply chain (56)
Tariffs (13)
The Weekly (9)
Vaccines (483)
Venture capital (29)
Weight loss (156)
Women's health (44)
Worklife (5)
Date
Today (48)
Last 7 days (357)
Last 30 days (1351)
Last 365 days (19485)
2026 (1907)
2025 (19569)
2024 (23612)
2023 (27116)
2022 (31296)
2021 (34737)
2020 (36418)
2019 (34740)
2018 (25460)
2017 (18182)
2016 (17697)
2015 (19894)
2014 (10005)
2013 (6821)
2012 (7190)
2011 (7968)
2010 (7172)
Location
Africa (295)
Alabama (55)
Alaska (6)
Arizona (144)
Arkansas (8)
Asia (26537)
Australia (5475)
California (7122)
Canada (2180)
China (924)
Colorado (343)
Connecticut (351)
Delaware (201)
Europe (43490)
Florida (1137)
Georgia (193)
Hawaii (1)
Idaho (38)
Illinois (585)
India (56)
Indiana (435)
Iowa (4)
Japan (287)
Kansas (41)
Kentucky (26)
Louisiana (21)
Maine (62)
Maryland (1015)
Massachusetts (4957)
Michigan (180)
Minnesota (347)
Mississippi (5)
Missouri (89)
Montana (34)
Nebraska (18)
Nevada (96)
New Hampshire (71)
New Jersey (2307)
New Mexico (24)
New York (2154)
North Carolina (847)
North Dakota (6)
Northern California (3504)
Ohio (218)
Oklahoma (16)
Oregon (18)
Pennsylvania (1433)
Puerto Rico (19)
Rhode Island (32)
South America (500)
South Carolina (60)
South Dakota (1)
Southern California (2835)
Tennessee (108)
Texas (1127)
United States (26240)
Utah (205)
Vermont (1)
Virginia (209)
Washington D.C. (38)
Washington State (643)
West Virginia (2)
Wisconsin (50)
Wyoming (2)
362,468 Results for "origin agritech limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Origin Agritech Announces Long-Term Revenue Projections Across Key Product Lines Through 2029
July 23, 2024
·
2 min read
Press Releases
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
December 11, 2025
·
7 min read
/C O R R E C T I O N -- Origin Agritech Limited/
Origin Agritech Ltd., an agriculture technology company, announced that the company has received an order for its hybrid corn worth RMB240 million, or roughly $35 million, from Muyuan Foods.
July 27, 2022
·
5 min read
Press Releases
Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs
September 26, 2025
·
5 min read
Origin Agritech Receives a $35 Million Order from Muyuan Foods
Origin Agritech Ltd., an agriculture technology company, announced that the company has received an order for its hybrid corn worth RMB240 million, or roughly $35 million, from Muyuan Foods.
July 27, 2022
·
4 min read
Press Releases
Children’s Hospital Los Angeles Researchers Discover Possible Cell of Origin for Ewing Sarcoma
October 13, 2025
·
5 min read
Press Releases
Haemonetics Acquires Vivasure Medical Limited
January 9, 2026
·
5 min read
Press Releases
Vera Therapeutics to Host an Investor Call and Webcast to Provide an ORIGIN 3 Update on November 6, 2025 at 4:30 pm ET
October 23, 2025
·
7 min read
Press Releases
Selonterra announces grant of United States patent on original discoveries in Alzheimer’s disease
August 19, 2025
·
1 min read
Press Releases
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
November 7, 2025
·
9 min read
1 of 36,247
Next
